BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 11441098)

  • 1. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
    Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
    J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
    Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
    J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Lipoprotein Rv1016c Derived from
    Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
    Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
    Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
    Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing of Mycobacterium tuberculosis antigen 85B involves intraphagosomal formation of peptide-major histocompatibility complex II complexes and is inhibited by live bacilli that decrease phagosome maturation.
    Ramachandra L; Noss E; Boom WH; Harding CV
    J Exp Med; 2001 Nov; 194(10):1421-32. PubMed ID: 11714749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.
    Gehring AJ; Dobos KM; Belisle JT; Harding CV; Boom WH
    J Immunol; 2004 Aug; 173(4):2660-8. PubMed ID: 15294983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
    Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
    J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
    Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
    J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
    Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
    Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function.
    Pecora ND; Gehring AJ; Canaday DH; Boom WH; Harding CV
    J Immunol; 2006 Jul; 177(1):422-9. PubMed ID: 16785538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.
    Noss EH; Harding CV; Boom WH
    Cell Immunol; 2000 Apr; 201(1):63-74. PubMed ID: 10805975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells.
    Tobian AA; Canaday DH; Harding CV
    J Immunol; 2004 Oct; 173(8):5130-7. PubMed ID: 15470057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.
    Reiling N; Hölscher C; Fehrenbach A; Kröger S; Kirschning CJ; Goyert S; Ehlers S
    J Immunol; 2002 Oct; 169(7):3480-4. PubMed ID: 12244136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.
    Bakhru P; Sirisaengtaksin N; Soudani E; Mukherjee S; Khan A; Jagannath C
    Cell Immunol; 2014 Jan; 287(1):53-61. PubMed ID: 24384074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
    Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
    Mukhopadhyay S; Peiser L; Gordon S
    J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins.
    Takeuchi O; Sato S; Horiuchi T; Hoshino K; Takeda K; Dong Z; Modlin RL; Akira S
    J Immunol; 2002 Jul; 169(1):10-4. PubMed ID: 12077222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.
    Edelson BT; Unanue ER
    J Immunol; 2002 Oct; 169(7):3869-75. PubMed ID: 12244184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
    Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
    J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.